References
1. M.M. Crowley et al., Drug Dev. Ind. Pharm.
33 (9), 909–926 (2007).
2. I. Ghebre-Sellassie and C. Martin, Pharmaceutical Extrusion Technology (Informa Healthcare, New York, Vol. 133, 2007).
3. J. Breitenbach, Eur. J. Pharm. Biopharm.
54 (2), 107–117 (2002).
4. J.E. Patterson et al., Int. J. Pharm.
336 (1), 22–34 (2007).
5. A. Foster, J. Hempenstall, and T. Rades, J. Pharm. Pharmacol.
53 (3), 303–315 (2001).
6. A. Forster et al., Int. J. Pharm.
226 (1–2), 147–161 (2001).
7. J.E. Patterson et al., Drug Dev. Ind. Pharm.
34 (1), 95–106 (2008).
8. S. Janssens et al., Eur. J. Pharm. Sci.
30 (3–4), 288–294 (2007).
9. S. Janssens and G. Van den Mooter, "Enhancing Solubility and Dissolution Rate of Poorly Soluble Drugs," WO 2007/115381,
Oct. 2007.
10. E. Karavas et al., Eur. J. Pharm. Biopharm.
63 (2), 103–114 (2006).
11. R.J. Chokshi et al., J. Pharm Sci.
94 (11), 2463–2474 (2005).
12. S. Thumma et al., Eur. J. Pharm. Biopharm.
70 (2), 605–614 (2005).
Citation: When referring to this article, please cite it as "M.Karl, D. Djuric, K.Kolter, "Pharmaceutical Excipients for Hot-Melt
Extrusion," Pharmaceutical Technology 35 (5) 74-82 (2011)."
|
